The price of Envista Holdings Corp (NYSE:NVST) shares last traded on Wall Street rose 5.69% to $23.78.
Based on available information, 11 analysts follow Envista Holdings Corp (NYSE:NVST). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $38.00 and a low of $22.00, we find $30.00. Given the previous closing price of $22.50, this indicates a potential upside of 33.33 percent. NVST stock price is now 0.04% away from the 50-day moving average and -25.33% away from the 200-day moving average. The market capitalization of the company currently stands at $4.08B.
Among analysts, 3 rate the stock a hold while 7 rate it a buy. Brokers who have rated the stock have averaged $29.44 as their price target over the next twelve months.
With the price target maintained at $22, Goldman recently Downgraded its rating from Buy to Sell for Envista Holdings Corp (NYSE: NVST).
In other news, Conley Eric, SVP, Orthodontics bought 2,185 shares of the company’s stock on Nov 16. The stock was bought for $50,015 at an average price of $22.89. Upon completion of the transaction, the SVP, Orthodontics now directly owns 47,376 shares in the company, valued at $1.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 08, General Counsel Nance Mark E bought 5,000 shares of the business’s stock. A total of $108,750 was incurred on buying the stock at an average price of $21.75. This leaves the insider owning 39,042 shares of the company worth $0.93 million. Insiders disposed of 129,634 shares of company stock worth roughly $3.08 million over the past 1 year. A total of 0.49% of the company’s stock is owned by insiders.
A candlestick chart of Envista Holdings Corp (NYSE: NVST) showed a price of $22.52 on Wednesday morning. During the past 12 months, Envista Holdings Corp has had a low of $20.00 and a high of $43.29. As of last week, the company has a debt-to-equity ratio of 0.38, a current ratio of 2.20, and a quick ratio of 1.82. According to the stock market information, the enterprise value for the company is $4.67B, which is based on a 21.95 price-to-earnings ratio, a 5.10 price-to-earnings-growth ratio, and a beta of 1.40. The fifty day moving average price for NVST is $23.77 and a two-hundred day moving average price translates $31.85 for the stock.
The latest earnings results from Envista Holdings Corp (NYSE: NVST) was released for Sep, 2023. According to the Medical Instruments & Supplies Company, earnings per share came in at $0.43, missing analysts’ expectations of $0.46 by -0.03. This compares to -$0.01 EPS in the same period last year. The net profit margin was 7.39% and return on equity was 4.62% for NVST. The company reported revenue of $631.3 million for the quarter, compared to $631.1 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 0.03 percent. For the current quarter, analysts expect NVST to generate $647.47M in revenue.
Envista Holdings Corp(NVST) Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant for treatment planning of dental implants; DTX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic, a software package offered with its imaging devices. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
